Skip to main content
. 2013 Jul 22;11(7):2655–2666. doi: 10.3390/md11072655

Figure 5.

Figure 5

Cellular Lipid Peroxidation Antioxidant Activity (CLPAA) results for barettin and debromobarettin. Barettin acts in a dose-dependent manner to reduce lipid peroxidation in HepG2 cells. This effect was not seen with the de-brominated molecule. Butylated hydroxytoluene (BHT; 10 μM) was used as a comparative control. Results are normalized to positive control with cumene hydroperoxide (CumOOH) (n = 3).